Teladoc Health (NYSE:TDOC) Stock Price Passes Below Fifty Day Moving Average – Time to Sell?

Teladoc Health, Inc. (NYSE:TDOC)’s share price crossed below its fifty day moving average during trading on Thursday . The stock has a fifty day moving average of $7.69 and traded as low as $7.12. Teladoc Health shares last traded at $7.2250, with a volume of 1,743,986 shares.

Wall Street Analyst Weigh In

TDOC has been the subject of a number of analyst reports. Bank of America reduced their target price on shares of Teladoc Health from $9.00 to $8.00 and set a “neutral” rating for the company in a research note on Tuesday, November 25th. Barclays started coverage on Teladoc Health in a report on Tuesday, December 9th. They set an “equal weight” rating and a $8.50 price target on the stock. Weiss Ratings reissued a “sell (e+)” rating on shares of Teladoc Health in a report on Monday. BMO Capital Markets assumed coverage on Teladoc Health in a research report on Thursday, November 13th. They issued a “market perform” rating and a $8.00 target price on the stock. Finally, Citigroup lifted their target price on Teladoc Health from $9.50 to $10.50 and gave the company a “neutral” rating in a research note on Tuesday, October 21st. Five equities research analysts have rated the stock with a Buy rating, twelve have given a Hold rating and one has given a Sell rating to the stock. According to data from MarketBeat.com, the stock has a consensus rating of “Hold” and an average target price of $9.60.

Teladoc Health Stock Performance

The stock has a market cap of $1.26 billion, a P/E ratio of -5.57 and a beta of 2.04. The company has a debt-to-equity ratio of 0.71, a current ratio of 2.70 and a quick ratio of 2.60. The company has a fifty day moving average of $7.66 and a 200 day moving average of $7.80.

Teladoc Health (NYSE:TDOC) last issued its quarterly earnings results on Wednesday, October 29th. The health services provider reported ($0.21) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.26) by $0.05. Teladoc Health had a negative return on equity of 10.59% and a negative net margin of 8.84%.The company had revenue of $626.44 million for the quarter, compared to analysts’ expectations of $625.66 million. During the same period last year, the firm earned ($0.19) EPS. The firm’s revenue for the quarter was down 2.2% on a year-over-year basis. Teladoc Health has set its Q4 2025 guidance at -0.250–0.100 EPS. On average, equities analysts predict that Teladoc Health, Inc. will post -1.16 earnings per share for the current fiscal year.

Insider Buying and Selling at Teladoc Health

In related news, insider Fernando M. Rodrigues sold 4,209 shares of the business’s stock in a transaction that occurred on Wednesday, December 3rd. The shares were sold at an average price of $7.48, for a total value of $31,483.32. The transaction was disclosed in a filing with the SEC, which can be accessed through this hyperlink. Also, insider Adam C. Vandervoort sold 5,720 shares of the stock in a transaction that occurred on Tuesday, December 2nd. The shares were sold at an average price of $7.49, for a total transaction of $42,842.80. Following the sale, the insider directly owned 80,732 shares of the company’s stock, valued at approximately $604,682.68. This represents a 6.62% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Insiders have sold a total of 33,288 shares of company stock valued at $251,684 in the last ninety days. 0.58% of the stock is owned by insiders.

Institutional Inflows and Outflows

Several institutional investors have recently modified their holdings of the stock. IFP Advisors Inc boosted its stake in shares of Teladoc Health by 412.1% during the 3rd quarter. IFP Advisors Inc now owns 3,989 shares of the health services provider’s stock worth $31,000 after acquiring an additional 3,210 shares in the last quarter. Aster Capital Management DIFC Ltd lifted its holdings in shares of Teladoc Health by 101.1% during the third quarter. Aster Capital Management DIFC Ltd now owns 4,823 shares of the health services provider’s stock valued at $37,000 after purchasing an additional 2,425 shares during the last quarter. Bayforest Capital Ltd purchased a new stake in shares of Teladoc Health during the third quarter valued at $58,000. Caitong International Asset Management Co. Ltd boosted its position in shares of Teladoc Health by 8,192.0% in the 2nd quarter. Caitong International Asset Management Co. Ltd now owns 8,292 shares of the health services provider’s stock valued at $72,000 after purchasing an additional 8,192 shares during the period. Finally, State of Alaska Department of Revenue purchased a new position in Teladoc Health in the 3rd quarter worth about $75,000. Institutional investors own 76.82% of the company’s stock.

Teladoc Health Company Profile

Teladoc Health, Inc is a leading global provider of virtual healthcare services, offering on-demand medical consultations via phone, video, and mobile app platforms. The company connects patients with licensed physicians and specialists for non-emergency medical issues, mental health support, dermatology, and chronic condition management. By leveraging digital technologies and data analytics, Teladoc aims to enhance accessibility, reduce healthcare costs, and improve patient outcomes through personalized care plans and remote monitoring.

Teladoc’s service portfolio includes general medical visits, behavioral health sessions, expert medical services for complex cases, and wellness programs designed to support chronic disease management such as diabetes, hypertension, and heart disease.